| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.006 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.0065 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |